Jan Bolinder

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jan Bolinder föddes 1952 i Västerås, tog läkarexamen vid Karolinska Institutet 1977 och disputerade där 1983. Samma år blev han specialist i allmän internmedicin och 1992 även i endokrinologi och diabetologi.

Åren 1983-85 innehade han en MFR/VR-finansierad forskartjänst på heltid och 1998-2004 på halvtid i klinisk diabetesforskning. Han blev 1985 docent vid Karolinska Institutet, och 1988 först biträdande överläkare därefter 1993 överläkare vid Centrum för metabolism och endokrinologi, Huddinge Universitetssjukhus.

Åren 1995-2003 var han sektionschef och områdesansvarig för diabetesvården vid kliniken, 2003 även tf verksamhetschef. Han är sedan 2004 prefekt vid institutionen för medicin, Karolinska Universitetssjukhuset, Huddinge.

Forskningsbeskrivning

Diabetes är en av våra stora folksjukdomar där framförallt den dramatiska ökningen av typ 2-diabetes, så kallad åldersdiabetes, utgör ett globalt hot mot folkhälsan.

Med mikrodialysteknik studerar forskargruppen hur frisättningen av fettsyror regleras i fettväv och muskelvävnad, och vilken betydelse detta har för utvecklingen av insulinresistens och typ 2-diabetes.

I olika samarbetsprojekt och kliniska studier studeras diabetesterapier och tekniker för kontinuerlig glukosmätning. Förekomst av diabetes och diabeteskomplikationer studeras av Diabetes Incidence Study in Sweden (DISS).

Artiklar

Article: DIABETOLOGIA. 2025;68(8):1647-1656
Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring
Eeg-Olofsson K; Nathanson D; Spelman T; Kyhlstedt M; Seibold A; Levrat-Guillen F; Bolinder J
Article: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2025;19(1):143-152
Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial
Pylov D; Polonsky W; Imberg H; Holmer H; Hellman J; Wijkman M; Bolinder J; Heisse T; Dahlqvist S; Nystrom T; Schwarz E; Hirsch I; Lind M
Article: DIABETOLOGIA. 2025;68(1):41-51
Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA_1c and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies
Nathanson D; Eeg-Olofsson K; Spelman T; Buelow E; Kyhlstedt M; Levrat-Guillen F; Bolinder J
Article: DIABETES CARE. 2024;47(12):2164-2171
Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Associated With Reduced Hospitalization for Acute Diabetes Events and Cardiovascular Complications in Adults With Type 1 Diabetes
Eeg-Olofsson K; Nathanson D; Spelman T; Kyhlstedt M; Bulow E; Levrat-Guillen F; Bolinder J
Article: DIABETOLOGIA. 2024;67(8):1517-1526
Discordance between mean glucose and time in range in relation to HbA_1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
Isaksson SS; Imberg H; Hirsch IB; Schwarcz E; Hellman J; Wijkman M; Bolinder J; Nystrom T; Holmer H; Hallstrom S; Olafsdottir AF; Pekkari S; Polonsky W; Lind M
Article: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2024;18(1):89-98
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
Nystroem T; Schwarz E; Dahlqvist S; Wijkman M; Ekelund M; Holmer H; Bolinder J; Hellman J; Imberg H; Hirsch IB; Lind M
Article: DIABETES THERAPY. 2023;14(9):1563-1575
Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study
Lind M; Catrina S-B; Ekberg NR; Gerward S; Halasa T; Hellman J; Hess D; Londahl M; Qvist V; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2022;24(S1):S35-S57
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Article: DIABETOLOGIA. 2021;64(7):1595-1603
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls
Nathanson D; Svensson A-M; Miftaraj M; Franzen S; Bolinder J; Eeg-Olofsson K
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2021;23(S2):S46-S68
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Article: DIABETES OBESITY & METABOLISM. 2021;23(2):619-630
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)
Olafsdottir AF; Bolinder J; Heise T; Polonsky W; Ekelund M; Wijkman M; Pivodic A; Ahlen E; Schwarcz E; Nystrom T; Hellman J; Hirsch IB; Lind M
Article: DIABETES CARE. 2021;44(1):141-149
Sustained Intensive Treatment and Long-term Effects on HbA_1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Lind M; Olafsdottir AF; Hirsch IB; Bolinder J; Dahlqvist S; Pivodic A; Hellman J; Wijkman M; Schwarcz E; Albrektsson H; Heise T; Polonsky W
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2019;21(S1):S57-S78
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2018;20(4):274-284
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
Olafsdottir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nystrom T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
Article: DIABETIC MEDICINE. 2018;35(4):491-494
Could FreeStyle Libre sensor glucose data support decisions for safe driving?
Rayman G; Kroeger J; Bolinder J
Article: DIABETOLOGIA. 2018;61(3):539-550
Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Kroeger J; Weitgasser R; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2018;20(S1):S55-S70
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2017;133:21-29
Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes - A retrospective observational nation-wide cohort study
Tyrberg M; Nystrom L; Arnqvist HJ; Bolinder J; Gudbjornsdottir S; Landin-Olsson M; Eriksson JW; Svensson MK
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2017;19(S1):S42-S58
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2017;317(4):379-387
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Olafsdottir AF; Frid A; Wedel H; Ahlen E; Nystrom T; Hellman J
Article: LANCET. 2016;388(10057):2254-2263
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kroeger J; Weitgasser R
Article: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2016;10(3):754-761
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Pehrsson N-G; Moström P
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2016;18:S43-S55
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Article: ACTA DIABETOLOGICA. 2015;52(3):581-589
Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors
Anderbro T; Gonder-Frederick L; Bolinder J; Lins P-E; Wredling R; Moberg E; Lisspers J; Johansson U-B
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2015;17:S39-S46
New Insulins and Insulin Therapy
Bolinder J; Danne T
Article: DIABETES-METABOLISM RESEARCH AND REVIEWS. 2015;31(2):138-146
The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors
Svensson MK; Tyrberg M; Nystrom L; Arnqvist HJ; Bolinder J; Ostman J; Gudbjornsdottir S; Landin-Olsson M; Eriksson JW
Article: ACTA DIABETOLOGICA. 2014;51(5):845-851
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study
Hommel E; Olsen B; Battelino T; Conget I; Schuetz-Fuhrmann I; Hoogma R; Schierloh U; Sulli N; Gough H; Castaneda J; de Portu S; Bolinder J
Article: DIABETOLOGIA. 2014;57(7):1375-1381
The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods
Rawshani A; Landin-Olsson M; Svensson A-M; Nystrom L; Arnqvist HJ; Bolinder J; Gudbjornsdottir S
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2014;16:S34-S43
New Insulins and Insulin Therapy
Danne T; Bolinder J
Article: DIABETES OBESITY & METABOLISM. 2014;16(2):159-169
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
Bolinder J; Ljunggren O; Johansson L; Wilding J; Langkilde AM; Sjostrom CD; Sugg J; Parikh S
Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(1):39-48
Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve
Sjostrand M; Carlson K; Arnqvist HJ; Gudbjornsdottir S; Landin-Olsson M; Lindmark S; Nystrom L; Svensson MK; Eriksson JW; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2013;15:S40-S47
New Insulins and Insulin Therapy
Danne T; Bolinder J
Article: DIABETOLOGIA. 2012;55(12):3155-3162
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
Battelino T; Conget I; Olsen B; Schuetz-Fuhrmann I; Hommel E; Hoogma R; Schierloh U; Sulli N; Bolinder J
Journal article: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2012;6(6):1498-1502
Reimbursement for continuous glucose monitoring: a European view.
Heinemann L; Franc S; Phillip M; Battelino T; Ampudia-Blasco FJ; Bolinder J; Diem P; Pickup J; Hans Devries J
Article: DIABETES OBESITY & METABOLISM. 2012;14(11):990-999
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
Ljunggren O; Bolinder J; Johansson L; Wilding J; Langkilde AM; Sjostrom CD; Sugg J; Parikh S
Article: JOURNAL OF INTERNAL MEDICINE. 2012;271(4):414-420
Adipose zinc-a2-glycoprotein is a catabolic marker in cancer and noncancerous states
Ryden M; Agustsson T; Andersson J; Bolinder J; Toft E; Arner P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2012;97(3):1020-1031
Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
Bolinder J; Ljunggren O; Kullberg J; Johansson L; Wilding J; Langkilde AM; Sugg J; Parikh S
Journal article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2012;(175):30-34
New insulins and insulin therapy.
Danne T; Bolinder J
Article: DIABETES CARE. 2011;34(4):795-800
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino T; Phillip M; Bratina N; Nimri R; Oskarsson P; Bolinder J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2011;96(4):1085-1092
Prolonged Exercise-Induced Stimulation of Skeletal Muscle Glucose Uptake Is due to Sustained Increases in Tissue Perfusion and Fractional Glucose Extraction
Hamrin K; Qvisth V; Hagstrom-Toft E; Enoksson S; Henriksson J; Bolinder J
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2011;65(170):26-30
New insulins and insulin therapy
Danne T; Bolinder J
Article: DIABETIC MEDICINE. 2011;28(2):156-161
Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults
Scholin A; Nystrom L; Arnqvist H; Bolinder J; Bjork E; Berne C; Karlsson FA
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2011;13(1):49-54
The SWITCH Study (Sensing With Insulin pump Therapy to Control HbA_1c): Design and Methods of a Randomized Controlled Crossover Trial on Sensor-Augmented Insulin Pump Efficacy in Type 1 Diabetes Suboptimally Controlled with Pump Therapy
Conget I; Battelino T; Gimenez M; Gough H; Castaneda J; Bolinder J
Article: DIABETIC MEDICINE. 2010;27(10):1151-1158
Fear of hypoglycaemia in adults with Type 1 diabetes
Anderbro T; Amsberg S; Adamson U; Bolinder J; Lins P-E; Wredling R; Moberg E; Lisspers J; Johansson U-B
Article: DIABETOLOGIA. 2010;53(6):1084-1092
Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings-evidence from annual registry data in 1990-2005
Carlsson KS; Landin-Olsson M; Nystrom L; Arnqvist HJ; Bolinder J; Ostman J; Gudbjornsdottir S
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2010;64(166):1-10
Self-monitoring of blood glucose
Garg S; Hirsch IB; Bode BW; Battelino T; Pickup J; Dassau E; Atlas E; Phillip M; Danne T; Bolinder J; Heinemann L; Kaufman N; Hod M; Jovanovic L; Spector D; Shikora S; Skyler JS; Zisser H; Riddell MC
Article: DIABETOLOGIA. 2008;51(12):2224-2232
Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients
Bakhtadze E; Cervin C; Lindholm E; Borg H; Nilsson P; Arnqvist HJ; Bolinder J; Eriksson JW; Gudbjornsdottir S; Nystrom L; Agardh C-D; Landin-Olsson M; Sundkvist G; Groop LC
Journal article: CURRENT DIABETES REVIEWS. 2008;4(3):218-222
Clinical Use of Real-Time Continuous Glucose Monitoring
Battelino T; Bolinder J
Article: JOURNAL OF INTERNAL MEDICINE. 2008;263(4):386-394
Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002
Ostman J; Lonnberg G; Arnqvist HJ; Blohme G; Bolinder J; Schnell AE; Eriksson JW; Gudbjornsdottir S; Sundkvist G; Nystrom L
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2008;93(1):240-246
Catecholamine regulation of local lactate production in vivo in skeletal muscle and adipose tissue:: Role of β-adrenoreceptor subtypes
Qvisth V; Hagstrom-Toft E; Enoksson S; Bolinder J
Journal article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2007;21(4):246-251
Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.
Torffvit O; Eriksson JW; Henricsson M; Sundkvist G; Arnqvist HJ; Blohmé G; Bolinder J; Nyström L; Ostman J; Svensson M
Article: JOURNAL OF CLINICAL PHARMACOLOGY. 2007;47(5):589-603
AAPS-FDA workshop white paper:: Microdialysis principles, application, and regulatory perspectives
Chaurasia CS; Muller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange ECM; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DLJ; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BWY; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Article: PHARMACEUTICAL RESEARCH. 2007;24(5):1014-1025
AAPS-FDA workshop white paper:: Microdialysis principles, application and regulatory perspectives
Chaurasia CS; Mueller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange ECM; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DLJ; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BWY; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Article: AAPS JOURNAL. 2007;9(1):E48-E59
AAPS-FDA workshop white paper:: Microdialysis principles, application, and regulatory perspectives report from the joint AAPS-FDA workshop, November 4-5, 2005, Nashville, TN
Chaurasia CS; Mueller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange ECM; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DLJ; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BWY; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;292(3):E709-E714
Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women
Qvisth V; Hagstrom-Toft E; Sjoberg MS; Bolinder J
Article: DIABETES CARE. 2007;30(1):71-76
C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
Ekberg K; Brismar T; Johansson B-L; Lindstrom P; Juntti-Berggren L; Norbhy A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Article: DIABETES CARE. 2006;29(12):2730-2732
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring
Deis D; Bolinder J; Riveline J-P; Battelino T; Bosi E; Tubiana-Rufi N; Kerr D; Phillip M
Article: DIABETOLOGIA. 2006;49(12):2847-2852
Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects:: results from the nationwide Diabetes Incidence Study in Sweden (DISS)
Littorin B; Blom P; Scholin A; Arnqvist HJ; Blohme G; Bolinder J; Ekbom-Schnell A; Eriksson JW; Gudbjornsdottir S; Nystrom L; Ostman J; Sundkvist G
Article: DIABETOLOGIA. 2006;49(8):1785-1794
HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden
Bakhtadze E; Borg H; Stenstrom G; Fernlund P; Arnqvist HJ; Ekbom-Schnell A; Bolinder J; Eriksson JW; Gudbjornsdottir S; Nystrom L; Groop LC; Sundkvist G
Article: DIABETOLOGIA. 2006;49(4):653-659
Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden
Waernbaum I; Blohmé G; Östman J; Sundkvist G; Eriksson JW; Arnqvist HJ; Bolinder J; Nyström L
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2006;91(2):665-670
Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo
Qvisth V; Hagström-Toft E; Enoksson S; Moberg E; Arner P; Bolinder J
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2005;65(7):585-594
Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes
Bolinder J; Fernlund P; Borg H; Arnqvist HJ; Björk E; Blohmé G; Eriksson JW; Nyström L; Östman J; Sundkvist G
Article: DIABETOLOGIA. 2005;48(5):946-953
Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo
Quisth V; Enoksson S; Blaak E; Hagström-Toft E; Arner P; Bolinder J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2005;90(2):1189-1195
Marked reutilization of free fatty acids during activated lipolysis in human skeletal muscle
Enoksson S; Hagström-Toft E; Nordahl J; Hultenby K; Pettersson N; Isaksson B; Permert J; Wibom R; Holm C; Bolinder J; Arner P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2004;89(9):4693-4700
Combined hyperinsulinemia and hyperglycemia, but not hyperinsulinemia alone, suppress human skeletal muscle lipolytic activity in vivo
Qvisth V; Hagström-Toft E; Enoksson S; Sherwin RS; Sjöberg S; Bolinder J
Article: DIABETIC MEDICINE. 2004;21(5):447-455
Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes
Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Östman J; Karlsson FA; Sundkvist G; Björk E
Article: CLINICAL THERAPEUTICS. 2004;26(5):724-736
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(3):384-391
Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden.
Schölin A; Björklund L; Borg H; Arnqvist H; Björk E; Blohmé G; Bolinder J; Eriksson JW; Gudbjörnsdottir S; Nyström L; Ostman J; Karlsson AF; Sundkvist G; Diabetes Incidence Study in Sweden
Article: DIABETES CARE. 2003;26(10):2903-2909
Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
Svensson M; Sundkvist G; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Henricsson M; Nyström L; Torffvit O; Waernbaum I; Ostman J; Eriksson JW; Diabetes Incidence Study in Sweden (DISS)
Article: JOURNAL OF INTERNAL MEDICINE. 2003;254(3):251-256
Increasing body mass index at diagnosis of diabetes in young adult people during 1983-1999 in the Diabetes Incidence Study in Sweden (DISS).
Littorin B; Nyström L; Gullberg B; Råstam L; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson JW; Scherstén B; Sundkvist G
Article: DIABETOLOGIA. 2003;46(2):173-181
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).
Borg H; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Nyström L; Jeppsson J-O; Sundkvist G
Article: DIABETES CARE. 2003;26(2):349-354
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes - Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
Henricsson M; Nyström L; Blohmé G; Östman J; Kullberg C; Svensson M; Schölin A; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Sundkvist G
Article: DIABETES. 2002;51(12):3376-3383
Marked heterogeneity of human skeletal muscle lipolysis at rest
Hagström-Toft E; Qvisth V; Nennesmo I; Rydén M; Bolinder H; Enoksson S; Bolinder J; Arner P
Article: JOURNAL OF INTERNAL MEDICINE. 2002;252(4):342-351
Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes
Sjöberg S; Ahrén B; Bolinder J
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2002;283(2):E295-E301
No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women
Moberg E; Sjöberg S; Hagström-Toft E; Bolinder J
Article: DIABETOLOGIA. 2002;45(6):783-791
The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998
Pundziute-Lyckå A; Dahlquist G; Nyström L; Arnqvist H; Björk E; Blohmé G; Bolinder J; Eriksson JW; Sundkvist G; Östman J
Article: DIABETES. 2001;50(7):1604-1611
Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo
Hagström-Toft E; Thörne A; Reynisdottir S; Mogberg E; Rössner S; Bolinder J; Arner P
Article: DIABETES CARE. 2001;24(6):1033-1037
Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults - A nationwide study
Littorin B; Björk E; Sundkvist G; Blohmé G; Nyström L; Bolinder J; Carlson A; Eriksson JW; Landin-Olsson M; Scherstén B; Östman J; Wibell L; Arnqvist HJ
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2001;86(3):1229-1234
Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo
Bertin E; Arner P; Bolinder J; Hagström-Toft E
Article: AUTOIMMUNITY. 2001;33(2):115-120
Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.
Törn C; Landin-Olsson M; Lernmark A; Scherstén B; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G
Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(5):387-396
Direct medical costs for patients with type 2 diabetes in Sweden
Henriksson F; Agardh CD; Berne C; Bolinder J; Lönnqvist F; Stenström P; Östenson CG; Jönsson B
Article: DIABETES-METABOLISM RESEARCH AND REVIEWS. 2000;16(6):442-447
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
Törn C; Landin-Olsson M; Östman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark Å
Article: CLINICAL TRANSPLANTATION. 2000;14(5):505-508
Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy
Tydén G; Tollemar J; Bolinder J
Article: DIABETES. 2000;49(5):797-802
Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects
Bolinder J; Kerckhoffs DAJM; Moberg E; Hagström-Toft E; Arner P
Article: DIABETIC MEDICINE. 2000;17(4):269-274
Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus -: a nationwide study
Östman J; Landin-Olsson M; Törn C; Palmer J; Lernmark Å; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
Article: DIABETIC MEDICINE. 1999;16(10):827-834
The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal
Landstedt-Hallin L; Arner P; Lins PE; Bolinder J; Olsen H; Groop L
Article: TRANSPLANTATION. 1999;67(5):645-648
Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation.
Tydén G; Bolinder J; Solders G; Brattström C; Tibell A; Groth CG
Article: DIABETES CARE. 1999;22(3):409-412
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.
Littorin B; Sundkvist G; Hagopian W; Landin-Olsson M; Lernmark A; Ostman J; Arnqvist HJ; Blohmé G; Bolinder J; Eriksson JW; Lithner F; Scherstén B; Wibell L
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1998;275(6):E909-E916
B-adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo
Hagström-Toft E; Enoksson S; Moberg E; Bolinder J; Arner P
Article: DIABETOLOGIA. 1998;41(11):1343-1354
Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes:: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway
Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
Article: CLINICAL SCIENCE. 1998;94(1):71-77
Lipolysis and lactate production in human skeletal muscle and adipose tissue following glucose ingestion
Kerckhoffs DAJM; Arner P; Bolinder J
Article: DIABETOLOGIA. 1997;40(11):1320-1326
Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia
Moberg E; HagstromToft E; Arner P; Bolinder J
Article: DIABETES CARE. 1997;20(10):1594-1597
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group.
Oskarsson P; Ljunggren JG; Lins PE
Article: HORMONE AND METABOLIC RESEARCH. 1997;29(9):440-443
Detection of hypoglycaemia by microdialysis measurements of glucose in subcutaneous adipose tissue
Moberg E; HagstromToft E; Bolinder J
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1997;273(3):E584-E592
Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood
HagstromToft E; Enoksson S; Moberg E; Bolinder J; Arner P
Article: DIABETOLOGIA. 1997;40(9):1070-1078
A circadian rhythm in lipid mobilization which is altered in IDDM
HagstromToft E; Bolinder J; Ungerstedt U; Arner P
Article: ACTA DIABETOLOGICA. 1997;34(1):10-17
Short term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy
Stenvinkel P; Bolinder J; Alvestrand A
Article: DIABETES CARE. 1997;20(1):64-70
Self-monitoring of blood glucose in type I diabetic patients: Comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions
Bolinder J; HagstromToft E; Ungerstedt U; Arner P
Article: NEW ENGLAND JOURNAL OF MEDICINE. 1996;335(12):860-863
Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts
Tyden G; Reinholt FP; Sundkvist G; Bolinder J
Article: NUTRITION. 1996;12(9):589-594
Carbohydrate three-carbon metabolism of adipose tissue during surgery
Fellander G; Bolinder J; Ungerstedt U; Arner P; Tjader I; Nordenstrom J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(8):2919-2924
Microdialysis of adipose tissue during surgery: Effect of local alpha- and beta-adrenoceptor blockade on blood flow and lipolysis
Fellander G; Eleborg L; Bolinder J; Nordenstrom J; Arner P
Article: DIABETOLOGIA. 1996;39(7):845-853
Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: Evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM
Bolinder J; Sjoberg S; Arner P
Article: INTERNATIONAL JOURNAL OF OBESITY. 1996;20(3):220-226
Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans
Fellander G; Linde B; Bolinder J
Article: ACTA DIABETOLOGICA. 1995;32(4):230-234
Effect of insulin on renal sodium handling and renal haemodynamics in insulin-dependent (type 1) diabetes mellitus patients
Stenvinkel P; OttossonSeeberger A; Alvestrand A; Bolinder J
Article: DIABETES. 1995;44(10):1170-1175
ROLE OF PHOSPHODIESTERASE-III IN THE ANTILIPOLYTIC EFFECT OF INSULIN IN-VIVO
HAGSTROMTOFT E; BOLINDER J; ERIKSSON S; ARNER P
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1994;78(1):150-155
LIPOLYSIS DURING ABDOMINAL-SURGERY
FELLANDER G; NORDENSTROM J; TJADER I; BOLINDER J; ARNER P
Journal article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1993;23(12):837-844
INFLUENCE OF INSULIN ON GLUCOSE-METABOLISM AND LIPOLYSIS IN ADIPOSE-TISSUE IN-SITU IN PATIENTS WITH LIVER-CIRRHOSIS
JOHANSSON U; ARNER P; BOLINDER J; HAGSTROMTOFT E; UNGERSTEDT U; ERIKSSON LS
Journal article: LANCET. 1993;342(8879):1080-1085
LONG-TERM CONTINUOUS GLUCOSE MONITORING WITH MICRODIALYSIS IN AMBULATORY INSULIN-DEPENDENT DIABETIC-PATIENTS
BOLINDER J; UNGERSTEDT U; ARNER P
Journal article: JOURNAL OF LIPID RESEARCH. 1993;34(10):1737-1743
EFFECT OF PHOSPHODIESTERASE INHIBITION WITH AMRINONE OR THEOPHYLLINE ON LIPOLYSIS AND BLOOD-FLOW IN HUMAN ADIPOSE-TISSUE IN-VIVO AS MEASURED WITH MICRODIALYSIS
ARNER P; HELLMER J; HAGSTROMTOFT E; BOLINDER J
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1993;76(2):392-398
ADRENERGIC REGULATION OF HUMAN ADIPOSE-TISSUE METABOLISM INSITU DURING MENTAL STRESS
HAGSTROMTOFT E; ARNER P; WAHRENBERG H; WENNLUND A; UNGERSTEDT U; BOLINDER J
Journal article: TRANSPLANTATION PROCEEDINGS. 1993;25(1):970
TRANSPLANTATION OF PORCINE FETAL ISLET-LIKE CELL CLUSTERS INTO 8 DIABETIC-PATIENTS
GROTH CG; ANDERSSON A; KORSGREN O; TIBELL A; TOLLEMAR J; KUMAGAIBRAESCH M; MOLLER E; BOLINDER J; OSTMAN J; BJOERSDORFF A; HELLERSTROM C
Journal article: DIABETOLOGIA. 1992;35(12):1177-1180
MICRODIALYSIS MEASUREMENT OF THE ABSOLUTE GLUCOSE-CONCENTRATION IN SUBCUTANEOUS ADIPOSE-TISSUE ALLOWING GLUCOSE MONITORING IN DIABETIC-PATIENTS
BOLINDER J; UNGERSTEDT U; ARNER P
Journal article: DIABETOLOGIA. 1992;35(11):1042-1048
EFFECTS OF INSULIN ON RENAL HEMODYNAMICS AND THE PROXIMAL AND DISTAL TUBULAR SODIUM HANDLING IN HEALTHY-SUBJECTS
STENVINKEL P; BOLINDER J; ALVESTRAND A
Journal article: DIABETOLOGIA. 1992;35(7):664-670
EFFECT OF INSULIN ON HUMAN ADIPOSE-TISSUE METABOLISM INSITU - INTERACTIONS WITH BETA-ADRENOCEPTORS
HAGSTROMTOFT E; ARNER P; JOHANSSON U; ERIKSSON LS; UNGERSTEDT U; BOLINDER J
Journal article: TRANSPLANTATION PROCEEDINGS. 1992;24(3):771-773
PANCREATIC TRANSPLANTATION WITH ENTERIC EXOCRINE DIVERSION - EXPERIENCE WITH 120 CASES
TYDEN G; TIBELL A; BOLINDER J; OSTMAN J; GROTH CG
Journal article: DIABETES. 1991;40(6):666-672
EFFECTS OF INSULIN DEPRIVATION AND REPLACEMENT ON INVIVO SUBCUTANEOUS ADIPOSE-TISSUE SUBSTRATE METABOLISM IN HUMANS
HAGSTROMTOFT E; ARNER P; NASLUND B; UNGERSTEDT U; BOLINDER J
Journal article: TRANSPLANTATION PROCEEDINGS. 1991;23(1):1667-1669
IMPROVED GLUCOSE COUNTERREGULATION AFTER PANCREAS TRANSPLANTATION IN DIABETIC-PATIENTS WITH UNAWARENESS OF HYPOGLYCEMIA
BOLINDER J; WAHRENBERG H; LINDE B; TYDEN G; GROTH CG; OSTMAN J
Journal article: DIABETOLOGIA. 1991;34(2):114-118
IMPAIRED INTRARENAL DOPAMINE PRODUCTION FOLLOWING INTRAVENOUS-SODIUM CHLORIDE INFUSION IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
STENVINKEL P; SAGGARMALIK AK; WAHRENBERG H; DICZFALUSY U; BOLINDER J; ALVESTRAND A
Journal article: ANALYTICAL BIOCHEMISTRY. 1991;192(1):237-242
GLUCOSE DETERMINATION IN SAMPLES TAKEN BY MICRODIALYSIS BY PEROXIDASE-CATALYZED LUMINOL CHEMILUMINESCENCE
NASLUND B; ARNER P; BOLINDER J; HALLANDER L; LUNDIN A
Journal article: JOURNAL OF INTERNAL MEDICINE. 1991;229(1):61-66
PANCREATIC AUTOANTIBODIES AND PANCREATIC FUNCTION IN SJOGRENS-SYNDROME
SUNDKVIST G; LINDAHL G; KOSKINEN P; BOLINDER J
Journal article: TRANSPLANT INTERNATIONAL. 1990;3(3):167-170
DOES COMBINED KIDNEY AND PANCREAS TRANSPLANTATION REVERSE FUNCTIONAL DIABETIC MICROANGIOPATHY
JORNESKOG G; OSTERGREN J; TYDEN G; BOLINDER J; FAGRELL B
Journal article: TRANSPLANTATION PROCEEDINGS. 1990;22(4):1593-1594
EXOCRINE AND ENDOCRINE FUNCTION OF PANCREATICODUODENAL GRAFTS VERSUS SEGMENTAL PANCREATIC GRAFTS
ELKADER MWA; TYDEN G; BOLINDER J; GROTH CG
Journal article: TRANSPLANTATION PROCEEDINGS. 1990;22(4):1582-1583
HIGH-INCIDENCE OF LATE REJECTIONS IN PREUREMIC RECIPIENTS OF PANCREAS TRANSPLANTS GIVEN ALONE OR IN COMBINATION WITH RENAL-TRANSPLANTS
TYDEN G; TIBELL A; BOLINDER J; OSTMAN J; GROTH CG
Journal article: AMERICAN JOURNAL OF PHYSIOLOGY. 1990;258(5):E888-E893
SUBCUTANEOUS ADIPOSE-TISSUE - A SOURCE OF LACTATE PRODUCTION AFTER GLUCOSE-INGESTION IN HUMANS
HAGSTROM E; ARNER P; UNGERSTEDT U; BOLINDER J
Journal article: DIABETES CARE. 1989;12(4):305-306
ULTRASONIC MEASUREMENT OF FOREARM SUBCUTANEOUS ADIPOSE-TISSUE THICKNESS SUITABLE FOR MONITORING OF SUBCUTANEOUS GLUCOSE-CONCENTRATION
BOLINDER J; FRID A
Journal article: DIABETES. 1989;38:94-96
LONG-TERM METABOLIC CONTROL IN RECIPIENTS OF SEGMENTAL-PANCREAS GRAFTS WITH PANCREATICOENTEROSTOMY OR DUCT OBSTRUCTION
TYDEN G; BRATTSTROM C; BOLINDER J; BOHMAN SO; GROTH CG; BREKKE IB; HOLDAAS H; FLATMARK A
Journal article: DIABETES. 1989;38:88-93
EFFECTS OF PANCREAS TRANSPLANTATION ON METABOLIC AND HORMONAL PROFILES IN IDDM PATIENTS
OSTMAN J; BOLINDER J; GUNNARSSON R; BRATTSTROM C; TYDEN G; WAHREN J; GROTH CG
Journal article: DIABETES. 1989;38:57-62
MARKERS FOR PANCREAS-GRAFT REJECTION IN HUMANS
BRATTSTROM C; TYDEN G; REINHOLT FP; BOHMAN SO; BORGSTROM A; BACKMAN L; BOLINDER J; GROTH CG
Journal article: AMERICAN JOURNAL OF PHYSIOLOGY. 1988;255(5):E737-E742
MICRODIALYSIS OF ADIPOSE-TISSUE AND BLOOD FOR INVIVO LIPOLYSIS STUDIES
ARNER P; BOLINDER J; ELIASSON A; LUNDIN A; UNGERSTEDT U
Journal article: TRANSPLANTATION PROCEEDINGS. 1988;20(3):475-478
METABOLIC EFFECTS OF LIVING RELATED PANCREATIC GRAFT DONATION
BOLINDER J; GUNNARSSON R; TYDEN G; BRATTSTROM C; OSTMAN J; GROTH CG
Journal article: TRANSPLANTATION PROCEEDINGS. 1988;20(3):471-474
PANCREATIC TRANSPLANTATION IN DIABETICS WITH PREUREMIC NEPHROPATHY
TYDEN G; BRATTSTROM C; BOLINDER J; REINHOLT F; OSTMAN J; LUNDGREN G; WILCZEK H; GROTH CG
Journal article: ACTA MEDICA SCANDINAVICA. 1988;224(5):451-459
ANTILIPOLYTIC EFFECT OF INSULIN IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS AFTER CONVENTIONAL TREATMENT WITH DIET AND SULFONYLUREA
BOLINDER J; ARNER P
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1987;65(4):732-737
STUDIES OF ACUTE EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN HUMAN FAT-CELLS
BOLINDER J; LINDBLAD A; ENGFELDT P; ARNER P
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1985;60(5):868-873
EFFECT OF FASTING ON INSULIN-RECEPTOR BINDING AND INSULIN ACTION IN DIFFERENT HUMAN SUBCUTANEOUS FAT DEPOTS
ENGFELDT P; BOLINDER J; OSTMAN J; ARNER P
Journal article: ACTA ENDOCRINOLOGICA. 1985;108(1):85-90
REVERSAL OF INSULIN RESISTANCE IN ADIPOSE-TISSUE OF NON-INSULIN-DEPENDENT DIABETICS BY TREATMENT WITH DIET AND SULFONYLUREA
BOLINDER J; OSTMAN J; ARNER P
Journal article: DIABETOLOGIA. 1984;27(4):447-453
BINDING AND MOLECULAR-WEIGHT PROPERTIES OF THE INSULIN-RECEPTOR FROM OMENTAL AND SUBCUTANEOUS ADIPOCYTES IN HUMAN OBESITY
LIVINGSTON JN; LEREA KM; BOLINDER J; KAGER L; BACKMAN L; ARNER P
Journal article: DIABETES. 1984;33(4):369-375
INFLUENCE OF THYROID-HORMONE LEVEL ON INSULIN ACTION IN HUMAN ADIPOSE-TISSUE
ARNER P; BOLINDER J; WENNLUND A; OSTMAN J
Journal article: JOURNAL OF CLINICAL INVESTIGATION. 1984;73(3):673-680
INFLUENCE OF OBESITY ON THE ANTILIPOLYTIC EFFECT OF INSULIN IN ISOLATED HUMAN FAT-CELLS OBTAINED BEFORE AND AFTER GLUCOSE-INGESTION
ARNER P; BOLINDER J; ENGFELDT P; HELLMER J; OSTMAN J
Journal article: INTERNATIONAL JOURNAL OF OBESITY. 1984;8(6):623-627
INSULIN-SECRETION IN HUMAN OBESITY - EFFECTS OF PROLONGED FASTING AND REFEEDING
BOLINDER J; ENGFELDT P; GUNNARSSON R
Journal article: DIABETES. 1983;32(10):959-964
INFLUENCE OF AGING ON INSULIN-RECEPTOR BINDING AND METABOLIC EFFECTS OF INSULIN ON HUMAN ADIPOSE-TISSUE
BOLINDER J; OSTMAN J; ARNER P
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1983;57(3):455-461
SITE DIFFERENCES IN INSULIN-RECEPTOR BINDING AND INSULIN ACTION IN SUBCUTANEOUS FAT OF OBESE FEMALES
BOLINDER J; ENGFELDT P; OSTMAN J; ARNER P
Journal article: ACTA DIABETOLOGICA LATINA. 1983;20(3):197-203
INSULIN DISSOCIATION FROM ITS RECEPTORS ON HUMAN FAT-CELLS - EVALUATION OF THE NEGATIVE COOPERATIVITY MODEL
ARNER P; BOLINDER J; OSTMAN J
Journal article: SCIENCE. 1983;220(4601):1057-1059
Glucose stimulation of the antilipolytic effect of insulin in humans.
Arner P; Bolinder J; Ostman J
Journal article: JOURNAL OF CLINICAL INVESTIGATION. 1983;71(3):709-714
MARKED INCREASE IN INSULIN SENSITIVITY OF HUMAN FAT-CELLS 1 HOUR AFTER GLUCOSE-INGESTION
ARNER P; BOLINDER J; OSTMAN J
Journal article: DIABETES. 1983;32(2):117-123
DIFFERENCES AT THE RECEPTOR AND POSTRECEPTOR LEVELS BETWEEN HUMAN OMENTAL AND SUBCUTANEOUS ADIPOSE-TISSUE IN THE ACTION OF INSULIN ON LIPOLYSIS
BOLINDER J; KAGER L; OSTMAN J; ARNER P
Journal article: INTERNATIONAL JOURNAL OF OBESITY. 1983;7(2):167-172
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
Arner P; Bolinder J; Engfeldt P; Lithell H
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1982;55(5):983-988
PHOSPHODIESTERASE ACTIVITY IN HUMAN SUBCUTANEOUS ADIPOSE-TISSUE IN INSULIN-DEPENDENT AND NONINSULIN-DEPENDENT DIABETES-MELLITUS
ENGFELDT P; ARNER P; BOLINDER J; OSTMAN J
Journal article: DIABETES. 1982;31(10):911-916
POSTRECEPTOR DEFECTS CAUSING INSULIN RESISTANCE IN NORMOINSULINEMIC NON-INSULIN-DEPENDENT DIABETES-MELLITUS
BOLINDER J; OSTMAN J; ARNER P
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1982;54(3):625-629
PHOSPHODIESTERASE ACTIVITY IN HUMAN SUBCUTANEOUS ADIPOSE-TISSUE IN HYPERTHYROIDISM AND HYPOTHYROIDISM
ENGFELDT P; ARNER P; BOLINDER J; WENNLUND A; OSTMAN J
Journal article: METABOLISM-CLINICAL AND EXPERIMENTAL. 1981;30(8):753-760
THE ANTI-LIPOLYTIC EFFECT OF INSULIN IN HUMAN ADIPOSE-TISSUE IN OBESITY, DIABETES-MELLITUS, HYPERINSULINEMIA, AND STARVATION
ARNER P; BOLINDER J; ENGFELDT P; OSTMAN J
Journal article: INTERNATIONAL JOURNAL OF OBESITY. 1981;5(6):665-670
REGULATION OF LIPOLYSIS IN HYPERTHYROIDISM
OSTMAN J; ARNER P; BOLINDER J; ENGFELDT P; WENNLUND A
Visa fler

Alla övriga publikationer

Editorial comment: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(10):937-938
CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion
Bolinder J
Published conference paper: DIABETES TECHNOLOGY & THERAPEUTICS. 2020;22(S1):S32-S46
New Insulins, Biosimilars, and Insulin Therapy
Danne T; Heinemann L; Bolinder J
Letter: DIABETOLOGIA. 2018;61(8):1879-1880
Flash glucose monitoring: objective, not self-referential, outcomes are needed. Reply to Warren RE [letter]
Bolinder J; Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Kroeger J; Weitgasser R
Letter: LANCET. 2017;389(10077):1396-1397
Cutaneous adverse events related to FreeStyle Libre device Reply
Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kroger J; Weitgasser R
Corrigendum: DIABETOLOGIA. 2006;49(6):1457
Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis:: a population-based study (DISS) in Sweden (vol 49, pg 1131, 2006)
Waernbaum I; Blohmé G; Ötman J; Sundkvist G; Eriksson JW; Arnqvist HJ; Bolinder J; Nyström L
Corrigendum: DIABETOLOGIA. 2004;47(1):154
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS) (vol 46, pg 173, 2003)
Borg H; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Nyström L; Jeppsson JO; Sundkvist G
Letter: DIABETOLOGIA. 2002;45(7):1043-1044
Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients
Bolinder J; Sjöberg S; Persson A; Ahrén B; Sundkvist G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(4):2535-2536
Experience with human islet transplantation in Sweden
Tibell A; Bolinder J; Hagström-Toft E; Tollemar J; Brendel M; Eckhard M; Brandhorst D; Bretzel RG; Korsgren O; Groth CG
Meeting abstract: TRANSPLANTATION. 1999;67(7):S223
Ten-year results with pancreatic transplantation:: Persistent normoglycemia and superior patient survival
Tydén G; Bolinder J; Brattström C; Groth CG
Letter: DIABETOLOGIA. 1998;41(12):1532-1533
Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus.
Sundkvist G; Tydén G; Karlsson FA; Bolinder J
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1998;30(7):3413
Diabetic patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone:: Outcome after 5 to 10 years
Groth CG; Bolinder J; Solders G; Brattström G; Tibell A; Tydén G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1998;30(2):634
Long-term metabolic control in recipients of segmental or whole-organ pancreatic grafts with enteric exocrine diversion and function beyond 5 years.
Tyden G; Bolinder J; Brattström C; Tibell A; Grott CG
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1998;30(2):332
A 10 year prospective study of IDDM patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone
Tydén G; Bolinder J; Solders G; Nakache R; Brattström C; Tibell A; Groth CG
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3124-3125
Early experience with a long-distance collaborative human islet transplant programme.
Tibell A; Brendel M; Wadström J; Brandhorst D; Brandhorst H; Eckhard M; Bolinder J; Bretzel RG; Groth CG
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3119
A 10-year prospective study of IDDM patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone
Tyden G; Bolinder J; Solders G; Nakache R; Brattstrom C; Tibell A; Groth CG
Letter: DIABETES CARE. 1997;20(7):1209
Self-monitoring of blood glucose compared with continuous tissue glucose measurement - Response to Sternberg et al.
Bolinder J; HagstromToft E; Arner P
Editorial comment: DIABETES, NUTRITION AND METABOLISM - CLINICAL AND EXPERIMENTAL. 1996;9(1):33-50
Hypoglycaemia warning on the basis of intracorporal glucose monitoring
Fischer U; Bendtson I; Bolinder J; Reach G; Guy RH
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3029-3030
Metabolic control in recipients of segmental pancreatic grafts functioning beyond 8 years
Tibell A; Tyden G; Bolinder J; Larsson M; Groth CG
Other: DIABETES CARE. 1995;18(8):1183-1186
COMPARISON OF BEDTIME NPH OR PREPRANDIAL REGULAR INSULIN COMBINED WITH GLIBENCLAMIDE IN SECONDARY SULFONYLUREA FAILURE
LANDSTEDTHALLIN L; ADAMSON U; ARNER P; BOLINDER J; LINS PE
Other: INTERNATIONAL JOURNAL OF OBESITY. 1995;19(5):350-354
INFLUENCE OF LOCAL BLOOD-FLOW ON GLYCEROL LEVELS IN HUMAN ADIPOSE-TISSUE
ENOKSSON S; NORDENSTROM J; BOLINDER J; ARNER P

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI